TIG3 is an important pro-differentiation regulator that is expressed in the suprabasal epidermis.
Introduction
The TIG3 tumor suppressor protein was originally discovered as a growth suppressor in human keratinocytes (DiSepio et al., 1998 ). Also called RIG1 and H-Rev107-2 (Huang et al., 2000; Jiang et al., 2005; Ou et al., 2008; Tsai et al., 2006; Tsai et al., 2007) , TIG3 displays homology to the human, mouse and rat forms of H-rev107 and is a member of the H-rev family of class II tumor suppressors and the NlpC/P60 superfamily (Deucher et al., 2000; DiSepio et al., 1998) . These proteins include an N-terminal hydrophilic domain and a c-terminal membrane-anchoring domain (Deucher et al., 2000; DiSepio et al., 1998) . The N-terminal domain encodes NCEHFV and LRYG sequence motifs that are conserved among family members (Anantharaman and Aravind, 2003) . Consistent with a role in reducing cell survival, TIG3 level is reduced in hyperproliferative keratinocytes present in psoriatic lesions and in skin tumor cells (Duvic et al., 1997; Duvic et al., 2000; Duvic et al., 2003) . Treating psoriatic lesions with vitamin A-related ligands increases TIG3 level which is associated with disease normalization (Duvic et al., 1997; Duvic et al., 2000; Duvic et al., 2003) .
Absence of TIG3 expression in monolayer keratinocytes is thought to be necessary for maintenance of proliferative potential (Sturniolo et al., 2003; Sturniolo et al., 2005) , and TIG3 expression in monolayer cultures causes cell death (Sturniolo et al., 2003; Sturniolo et al., 2005) .
TIG3 is present at high levels in differentiated human keratinocytes in suprabasal epidermis and in raft cultures (Jans et al., 2008) . TIG3-dependent death is associated with activation of selected differentiation-associated processes. For example, TIG3 distributes to the plasma membrane where it interacts with type I transglutaminase, an interaction that leads to increased transglutaminase activity and cornified envelope formation (Sturniolo et al., 2003; Sturniolo et al., 2005) . Mutagenesis studies indicate that TIG3 mutants lacking the c-terminal membrane-anchoring domain are not active (Deucher et al., 2000; Sturniolo et al., 2003; Sturniolo et al., 2005) . In contrast, N-terminal truncation converts TIG3 into a protein that causes keratinocyte apoptosis (Jans et al., 2008) . TIG3 also suppresses keratinocyte proliferation (Sturniolo et al., 2003; Sturniolo et al., 2005) ; however, very little is known about the mechanism of suppression.
The centrosome is an important organelle located adjacent the nucleus that serves to nucleate microtubule arrays which organize cytoplasmic organelles and primary cilia in interphase cells, and form the mitotic spindles during mitosis (Doxsey et al., 2005) . It includes two perpendicularly-oriented barrel-shaped centrioles surrounded by pericentriolar material (PCM) (Doxsey et al., 2005; Kreitzer et al., 1999) . Centrosome function is absolutely required for cell survival and cell division. Our studies suggest that TIG3 association with the centrosome alters microtubule distribution, increases microtubule stability, reduces microtubule anterograde elongation and suppresses daughter centrosome separation. We propose that TIG3 interaction at the centrosome is a key event in TIG3-dependent cessation of cell proliferation. Fig. 1A , TIG3 distributes at three major locations in cells: the plasma membrane, punctate intracellular foci, and at a perinuclear location. The perinuclear location is identified by arrows in Fig. 1A . We previously showed that the hydrophobic cterminus of TIG3 is required for appropriate TIG3 subcellular localization (Deucher et al., 2000) .
Results

TIG3 localizes at the centrosome As shown in
Indeed, Fig. 1A shows that a mutant that lacks the c-terminus, TIG3(1-134), displays a diffuse cytoplasmic distribution and does not display perinuclear accumulation. We have not studied this mutant further in the present studies, because it is inactivate and has no ability to modulate cell function (Jans et al., 2008; Sturniolo et al., 2003; Sturniolo et al., 2005) . Because TIG3 suppresses cell proliferation, we are particularly interested in the intense staining observed adjacent the nucleus (Fig. 1A, arrows) . This location suggests TIG3 interaction with the centrosome. To test this possibility, we stained cells to detect TIG3, the centriole protein, -tubulin, and a centrosome marker, pericentrin. Fig. 1B shows that TIG3 staining surrounds -tubulin and pericentrin (arrows) (Nigg and Raff, 2009) . Quantitative cell counts revealed TIG3 centrosomal localization in 93 + 2% of TIG3 expressing cells. Additionally, cells were stained with the Golgi markers, GM130 and mannose 6 phosphate receptor (M6PR), and calnexin, an endoplasmic reticulum marker. GM130, M6PR, and calnexin stained structures in the vicinity of the centrosome and some of this staining co-localized with TIG3 staining. The Manders' overlap coefficient was calculated to determine the extent of TIG3 localization with these organelle markers (Fig. 1C) . TIG3 displays high localization with the centrosome markers and low localization with the nucleus. In addition, some TIG3 localizes with M6PR, GM130 and calnexin. Thus, TIG3 colocalizes mostly with the centrosome but some also localizes with the Golgi and ER.
TIG3 alters microtubule distribution and stability As part of the search for a centrosome-specific role for TIG3, we examined the TIG3 impact on microtubules. The centrosome is a key controller of microtubule function during mitosis and in interphase cells (Doxsey et al., 2005) . We therefore assessed if TIG3 localization at the centrosome perturbs microtubule distribution. Fig. 2 compares the microtubule network in empty (EV) and TIG3 vector-infected cells. Empty vector-infected cells display a typical microtubule network which includes a perinuclear halo organized at the centrosome that sweeps around the nucleus and out to the cell periphery (Fig. 2, left) . In contrast, in TIG3 expressing cells, the microtubules distribute as a broad band at the cell periphery linked to the centrosome by thin microtubule threads (Fig. 2, right) .
These findings indicate that TIG3 influences microtubule distribution, and suggests it may also influence other microtubule properties. We used four approaches to assess the impact of TIG3 on microtubule stability. First, we examined the effect of nocodazole on microtubule integrity.
Microtubules in TIG3-negative (EV) cells are distributed throughout the cell (Fig. 3A) . Nocodazole treatment produces diffuse high-intensity staining which is typical of dissociated microtubules, and, as expected, withdrawal of nocodazole results in formation of asters (sites of microtubule reassembly) at the centrosome (arrows) (Fig. 3A) . In contrast, in TIG3-expressing cells, microtubules concentrate at the centrosome and in a thick band at the cell periphery with thin microtubule projections linking these locations (Fig. 3B) . These microtubules display a different response to nocodazole. Nocodazole treatment eliminates the peripheral tubulin band in most cells, but the centrosome-localized asters (arrows) survive nocodazole treatment (Fig. 3B, right panel) . The merged images show TIG3 (arrows) accumulation at the centrosome (Fig. 3B, left panel) . To provide quantitative information, we infected cells with tAd5-EV or tAd5-TIG3 and after 24 h counted the number of cells displaying a peripheral tubulin ring, tubulin at the centrosome, or tubulin at both locations. In untreated cells, centrosome-localized microtubules are visible in 19.8 + 3.1% of cells and no cells have a peripheral microtubule ring (Fig. 3C ). This value is probably an underestimate, as the asters may be obscured (Fig. 3D) . These findings suggest that microtubule status is very different in EV and TIG3 cells.
As a second method to assess microtubule status, we measured the amount of -tubulin in the non-soluble (pellet) fraction. Previous studies indicate that polymerized/stabilized -tubulin distributes in the 15,000 x g pellet fraction (Onishi et al., 2007) . At 24 h after tAd5-EV or tAd5-TIG3 infection, keratinocytes were harvested, total extract and pellet fraction were prepared, and -tubulin level was monitored in each fraction. These experiments show a substantial increase in the level of -tubulin present in the pellet fraction in TIG3-positive cells (Fig. 4A) . As a third method, we measured the effect of TIG3 on -tubulin acetylation and detyrosination. -tubulin detyrosination, to form glu--tubulin, is associated with increased microtubule stability, as is -tubulin acetylation (Bulinski and Gundersen, 1991; Kreitzer et al., 1999; Maruta et al., 1986; Thyberg and Moskalewski, 1999) . Fig.   4B shows that TIG3 expression leads to increased levels of acetylated -tubulin and glu--tubulin. To determine whether the acetyl--tubulin is localized to a particular region of the microtubule network, we stained EV and TIG3 cells with anti-acetyl--tubulin. Fig. 4C shows that acetyl--tubulin is distributed throughout the cell in EV cells. In TIG3-positive cells it is distributed in a ring at the cell periphery and at the centrosome. Anti--tubulin staining is included to confirm microtubule distribution (Fig. 4C) . Monitoring acetyl--tubulin distribution in individual cells (Fig. 4D) reveals that acetyl--tubulin distributes at the cell periphery and centrosome in TIG3-positive cells. Thus, the level of acetylated--tubulin is increased in TIG3-positive cells and is present in the tubulin network at both the centrosome and peripheral ring and glu--tubulin level is also increased. These studies suggest that microtubules are stabilized in TIG3-expressing cells.
As a fourth approach, we determined whether TIG3 affects microtubule growth using the microtubule plus end binding protein EB1-GFP to monitor anterograde microtubule extension (Dixit et al., 2009; Piehl et al., 2004; Piehl and Cassimeris, 2003) . EB1-GFP specifically binds to the growing plus end of microtubules and can be used to trace movement of the leading tip of the microtubule as it grows towards the cell periphery (Dixit et al., 2009; Piehl et al., 2004) . Keratinocytes were transfected with pEB1-GFP in the presence of pcDNA3 or pcDNA3-TIG3. At 18 h post-transfection, the cells were monitored for EB1-GFP distribution by fluorescence confocal microscopy. EV cells display robust plus end microtubule growth (Fig. 5, EV) . TIG3-expressing cells, in contrast, display substantial EB1-GFP accumulation in the vicinity of the centrosome (arrows) with reduced plus-end growth towards the cell periphery. These results suggest that TIG3 reduces anterograde microtubule extension and that extension of many microtubules is halted before extension is complete. In addition, EB1-GFP appears to label multiple foci in the vicinity of the centrosome, suggesting that the structure of the centrosome nucleation site(s) may have changed.
Impact of TIG3 on centrosome function The centriole and centrosome play a key role at all stages of the cell cycle (Lim et al., 2009; Loncarek et al., 2008; Sekine-Suzuki et al., 2008) .
Centrosomes replicate simultaneously with nuclear DNA during S phase (Doxsey et al., 2005) and during prophase of mitosis, and the daughter centrosomes separate and move to opposite poles of the mitotic cell (Doxsey et al., 2005; Lim et al., 2009; Loncarek et al., 2008) . Because of the role of centrosomes and microtubules in this process, an obvious expectation is that TIG3 may impede these processes.
Indeed, our studies suggest that TIG3 interferes with centrosome separation.
Keratinocytes were infected with TIG3 expressing virus and after 24 h were stained with anti-TIG3
and anti--tubulin. We next assessed the role of microtubules in regulating centrosome separation. Our goal was to assess whether TIG3 suppresses centrosome separation via an impact on microtubules. To study this, we monitored the impact of the microtubule disruptor, nocodazole, on centrosome separation in control (EV) and TIG3-expressing cells. In EV-infected cells, nocodazole treatment decreased the number of cells displaying separated centrosomes from 20 + 7% to 14 + 8%, a number that returned to 27 + 6% following nocodazole removal (recovery (Fig. 8) . These findings indicate that an intact microtubule network is necessary for efficient centrosome separation and that microtubule status influences centrosome function. In contrast, centrosome separation was observed in less than 2% of TIG3-expressing cells and this was not further reduced by nocodazole treatment.
Suppressing centrosome separation is expected to impede cell cycle progression. To assess this, keratinocytes were infected with tAd5-TIG3 or tAd5-EV and after 24 h incubated for 4 h with BrdU.
BrdU is incorporated into DNA specifically during new DNA synthesis in S phase. Parallel cultures were stained to detect phosphorylated histone H3, an M phase marker. Increased H3 phosphorylation is observed in mitosis (Goto et al., 1999; Tapia et al., 2006) . Fig. 9A shows the reduction in the number of BrdU-positive nuclei (green) from 14 + 1% in TIG3-negative cells to 1.1 + 0.3% of TIG3-positive cells. Similarly, TIG3-expressing cells display parallel reduction in the mitosis marker, phosphorylated histone H3 (Fig. 9A ). This suggests that TIG3 reduces both S and M phase cell cycle progression. To determine if these changes are due to a change in level of cell cycle control proteins, we monitored for changes in level by immunoblot. No change in cell cycle regulatory protein level is observed in TIG3-expressing cells (Fig. 9B) , suggesting that the reduced cell proliferation is not due to change in cell cycle regulator expression.
Discussion
We previously reported that TIG3 reduces cell survival (Jans et al., 2008; Scharadin et al., 2011; Sturniolo et al., 2003) ; however, little is known about the mechanism of growth suppression. In the present study we show that TIG3 localizes at the centrosome, as evidenced by co-localization with the centriole and centrosome markers, -tubulin and pericentrin. The centrosome is a 1 -2 m diameter organelle, located adjacent the nucleus that includes two perpendicularly-oriented barrel-shaped centrioles surrounded by pericentriolar material (PCM). The TIG3 staining pattern suggests that TIG3 interacts with the pericentriolar material (PCM). Moreover, the interaction is relatively specific. Some TIG3 is present localized with the Golgi (GM130, M6PR) and endoplasmic reticulum (calnexin), but the major site of TIG3 interaction is at the centrosome. The centrosome is absolutely required for cell division and cell survival, as it serves to nucleate polarized microtubule arrays which organize cytoplasmic organelles and primary cilia in interphase cells, and also forms the mitotic spindles during mitosis (Doxsey et al., 2005) . The PCM includes hundreds of proteins, including many large scaffold proteins that function as regulatory protein docking sites (Doxsey et al., 2005) , and the -tubulin ring complexes responsible for microtubule nucleation (Doxsey et al., 2005; Kreitzer et al., 1999) . The centrosome and the microtubule system are intimately connected, and deficiencies in either microtubule or centrosome function can reduce cell survival (Mazzorana et al., 2011; Rusan and Rogers, 2009) . Moreover, because the centrosome and microtubules reciprocally influence the function of the other, we studied the impact of TIG3 on both the centrosome and the microtubules.
TIG3 alters microtubule distribution, covalent modification and nucleation One feature we observe is a striking impact of TIG3 on microtubule nucleation. EB1-GFP is a probe that labels the growing ends of microtubules and is a useful probe to study nucleation (Piehl et al., 2004; Piehl and Cassimeris, 2003) . In TIG3 positive cells, EB1-GFP intensely labels the microtubule organizing center (MTOC) which suggests that TIG3 does not inhibit microtubule nucleation. However differences are observed. First, there appear to be multiple sites of nucleation, suggesting that the nucleation sites may be rearranged, and, second, the nucleated microtubules do not appear to elongate much beyond the region surrounding the centrosome. This suggests that although nucleation is ongoing, the fate of the nucleated microtubules is different from microtubules in control cells.
A second feature is that the microtubules display an unusual distribution in TIG3-positive cells. In control cells the microtubules extend around the nucleus and project in a continuous network to the cell periphery. In TIG3-expressing cells microtubules accumulate as a ring at the cell periphery, leaving thin microtubule threads to connect this structure to the centrosome. It has been shown that the microtubule network is reoriented in suprabasal keratinocytes such that it distributes to the cell periphery (Lechler and Fuchs, 2007) and it is at least possible that TIG3 drives this rearrangement, as it is expressed in suprabasal epidermis (Jans et al., 2008; Sturniolo et al., 2003; Sturniolo et al., 2005) .
Microtubule accumulation at the cell periphery could also be due to microtubule nucleation at alternate sites (e.g., at the cell periphery). However, our EB1-GFP studies suggest that the centrosome is maintained as the primary nucleation site in TIG3 positive cells. Alternatively, the altered microtubule distribution could be due to differences in microtubule anchoring. A specific set of proteins are involved in anchoring the negative end of microtubules to the centrosome. Ninein is a centrosome protein involved in this process (Dammermann and Merdes, 2002; Delgehyr et al., 2005; Mogensen et al., 2000) that has been shown to redistribute to the plasma membrane in differentiated keratinocytes (Lechler and Fuchs, 2007) and this redistribution results in formation of a cortical microtubule ring in these cells which is reminiscent of the peripheral ring that we observe. It is also possible that TIG3 may catalyze release of the microtubule minus end from the centrosome leading to peripheral accumulation. Although defining a precise mechanism will require further investigation, the present studies show that TIG3 alters the microtubule distribution.
A third feature is the impact of TIG3 on microtubule response to nocodazole. In control cells, microtubule asters completely dissociate following nocodazole treatment. In contrast, centrosomeassociated asters persist in nocodazole-treated TIG3-expressing cells. The possibility that it is due to a high rate of nucleation is supported by the EB1-GFP labeling studies showing a high rate of nucleation and by studies showing rapid expansion of asters upon nocodazole removal. However, increased aster maintenance could also be due to enhanced microtubule stability.
An additional interesting response to nocodazole is the preferential loss of the peripheral tubulin ring, a structure specifically present in TIG3 positive cells. Nocodazole treatment results in a complete loss of this structure. It is not clear why this ring structure forms in TIG3 positive cells, since microtubule elongation appears to cease in the vicinity of the centrosome. However, these rings reappear during recovery from nocodazole, suggesting that ring formation is not a one-time response to TIG3. An additional feature is that microtubules are not visible by immunostaining in approximately 50% of TIG3 positive cells. This is in spite of the fact that tubulin level is not decreased as measured by immunoblot. The absence of signal is not likely due to epitope masking, as the reduction is observed with each of three antibodies that detect different tubulin epitopes (rabbit anti--tubulin, mouse anti--tubulin and mouse anti-acetyl--tubulin).
We also examined whether TIG3 expression covalently modifies microtubules to alter stability. Moreover, we observe increased levels of insoluble tubulin in TIG3-positive cells, which is also an indicator of increased microtubule stability. Thus, TIG3 appears to increase microtubule stability. A key question is how the TIG3 impact on microtubules may influence cell survival and centrosome function. In this respect, centrosome and microtubule functions are linked together. It is known that the centrosome influences microtubule function and it is also known that agents that influence microtubule turnover or stability, such as paclitaxel, influence centrosome function (Lanzi et al., 2001; Mazzorana et al., 2011) . Thus, we propose that the one way that TIG3 reduces cell survival and halts proliferation is via its impact on microtubule distribution and stability, and that this also impacts the centrosome.
TIG3 halts daughter centrosome separation Centrosome localization of TIG3 could be expected to impact centrosome separation. Indeed, centrosome separation is impeded in TIG3-positive cells and this is associated with reduced cell proliferation as measured by reduced incorporation of BrdU into DNA (an S-phase event), and reduced levels of phospho-H3 (an M-phase marker). In control cultures, 15% of cells are BrdU positive and 10% display high-level phospho-H3 staining. In contrast, in TIG3 expressing cultures these levels are suppressed to less than 1% suggesting an impact of TIG3 on cell cycle progression. This is not associated with changes in expression of cell cycle control proteins associated with G1, S or G2/M, suggesting that it may uniformly impact all cell cycle phases.
Centrosomes are duplicated during the S-phase of the cell cycle in synchrony with nuclear DNA replication (Doxsey et al., 2005; Hinchcliffe and Sluder, 2001) . During early prophase the centrosomes separate and begin the process of migration to opposite poles of the dividing cell (Doxsey et al., 2005; Hinchcliffe and Sluder, 2001 ). Our studies suggest that TIG3 does not inhibit centrosome duplication, but rather inhibits centrosome separation and thereby influences cell division.
Indeed our findings show that the daughter centrosomes are separated by more than 1.5 m in 15.9%
control cells, a number that is consistent with the number of cells in mitosis (10.2%). In contrast, centrosome separation is observed in less than 1% of TIG3-positive cells, suggesting that TIG3 inhibits centrosome separation and/or centrosome migration. Time course studies reveal that TIG3
does not delay but actually halts separation. Proteins have been identified that link the mother and daughter centrosomes during replication that are cleaved to permit centrosome separation at the appropriate cell cycle stage (Bahe et al., 2005) . It is possible that TIG3 impedes the cleavage of these proteins and thereby inhibits centrosome separation. TIG3 may also inhibit centrosome replication. However, the number of cells containing duplicated centrosomes was not significantly reduced in TIG3-expressing cells. Thus, TIG3 does not inhibit centrosome replication.
In summary, our studies show that the centrosome is a major site of TIG3 localization in normal human keratinocytes, and that this is associated with changes in microtubule distribution, elongation and covalent modification, and that TIG3 association at the centrosome suppresses centrosome separation (Fig. 10) . In addition, we suggest that the altered microtubule environment may feedback to further alter centrosome function. Ultimately, we argue that these events lead to cessation of cell proliferation and reduce cell survival.
Material and Methods
Cell Culture and Reagents Primary cultures of human foreskin keratinocytes were cultured in 0.09 mM calcium-containing keratinocyte serum-free medium (KSFM) (Sturniolo et al., 2005) . Rabbit polyclonal anti-TIG3 has been described (Deucher et al., 2000) . TIG3 adenovirus tAd5-EV, tAd5-TIG3(1-164) and tAd5-TIG3(1-134) adenoviruses have been described (Jans et al., 2008; Sturniolo et al., 2003; Sturniolo et al., 2005) . tAd5 adenovirus encodes the tetracycline operator element linked to the cytomegalovirus promoter. This promoter is active in the presence of a transactivator (TA) protein, which is provided by co-infection with an Ad5-TA adenovirus (Jans et al., 2008; Sturniolo et al., 2005) . tAd5-EV is an empty adenovirus and tAd5-TIG3 encodes the full-length 164 amino acid TIG3 protein (Jans et al., 2008; Sturniolo et al., 2005) .
TIG3 ( Microtubule nucleation assay EB1 is a microtubule plus end binding protein that exchanges continuously and labels the plus end of microtubule (Piehl et al., 2004; Piehl and Cassimeris, 2003) .
Normal keratinocytes, growing in glass bottom dishes, were transfected with 1 g of plasmid encoding EB1-EGFP fusion protein (EB1-GFP) (Piehl et al., 2004; Piehl and Cassimeris, 2003) in the presence of 2 g of pcDNA3 or pcDNA3-TIG3(1-164) (Jans et al., 2008; Sturniolo et al., 2003; Sturniolo et al., 2005) . After 18 h EB1-GFP was detected using an Olympus FluoView FV1000 laser confocal microscope and a 60X objective with 3 second intervals between image capture. of TIG3 with various organelles was calculated using the Manders' overlap coefficient (0 indicates no co-localization, 1 indicates 100% co-localization) using confocal imaging. There is a strong tendency for TIG3 to localize at the centrosome, as detected by co-localization with -tubulin and pericentrin, but TIG3 also localizes, to a lesser extent, with the ER (calnexin) and Golgi (GM130 and M6PR).
M6PR overlap is statistically less than centrosome overlap and statistically more than GM130 and calnexin overlap (* indicates p < 0.007). TIG3 does not localize with the nucleus. 
